Heart-Assist Devices, Heart Transplant Infection, Infections
Conditions
Brief summary
Heart failure is a major cause of mortality and morbidity in children. Heart transplantation can significantly improve the prognosis of patients with severe heart failure, but access is limited by a shortage of transplants. Long-term mechanical circulatory support is a major advance in the management of heart failure and can provide haemodynamic support while awaiting myocardial recovery or heart transplantation. The Berlin Heart (BH) EXCOR is the only long-term support system available for children. Despite technical and medical advances in circulatory support, infection is a common complication and a major cause of morbidity and mortality in patients on BH. There are few studies on the management of infection with mechanical support. Current ISHLT (International Society for Heart and Lung Transplantation) recommendations are based on expert opinion and observational studies. Some experts recommend anti-infective therapy until transplantation for specific support infections or for support-associated infections with persistent bacteraemia.
Interventions
DEVICEVentricular Assist Device with Berlin Heart EXCOR
The Berlin Heart® EXCOR is a type of artificial heart pump that pulls blood from the ventricle and then sends that blood to the aorta or pulmonary trunc, thereby taking away extra work from the native heart. The device, which comes in several sizes, is not totally implanted inside the body.
Sponsors
Hospices Civils de Lyon
Claude Bernard University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
1 Days to 18 Years
Healthy volunteers
No
Inclusion criteria
* patients under 18yo of age with Berlin Heart assisting device in Hospices Civils de Lyon, in France.
Exclusion criteria
* patients over 18 yo at the time of BH assistance * unavailable documentation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Relapse of VAD-infection after discontinuation of anti-infective therapy | 3 months | Clinical and microbiological diagnosis of recurrence of infection with the same pathogen within 3 months of cessation of anti-infective therapy for a VAD-specific or VAD-related infection. |
Countries
France
Contacts
Primary ContactCharlotte Leclercq, MD PhD
Backup ContactMarc Lilot, MCU
Outcome results
None listed